TARA LAWRENZ: Open Payments
NPI 1396441911 · AUGUSTA, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$236 in 12 payments from 8 companies in 2025. Trend: 2023 $117 · 2024 $399 · 2025 $236
Food & beverage: $236
| Company | Payments | Amount |
|---|---|---|
| Corium, LLC | 2 | $45 |
| Otsuka America Pharmaceutical, Inc. | 2 | $37 |
| Axsome Therapeutics, Inc. | 2 | $36 |
| Vanda Pharmaceuticals Inc. | 2 | $34 |
| Supernus Pharmaceuticals, Inc. | 1 | $29 |
| ABBVIE INC. | 1 | $22 |
| Almatica Pharma LLC | 1 | $18 |
| Neurocrine BioSciences, Inc. | 1 | $16 |
Products named: Azstarys, REXULTI, Auvelity, FANAPT, Qelbree, VRAYLAR, LOREEV XR, INGREZZA.
Industry payments across KS — which companies pay providers there.
